Sponsor Pipeline

Radiopharm Theranostics, Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
5
Recruiting
10
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-19 NCT05799274
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other…
date change Primary completion pushed: 2026-05 -> 2026-08
2026-07-19 NCT05799274
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other…
date change Completion pushed: 2026-05 -> 2026-08
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Phase 1
2
Early Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06777433 Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases Brain Metastases From Solid Tumors Active, Not Recruiting
Phase 1/2
NCT07189871 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or… Castration-Resistant Prostate Cancer (CRPC) Recruiting
NCT07259213 A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC Castration-resistant Prostate Cancer Recruiting
Phase 1
NCT05799274 Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other… Healthy Volunteers Recruiting
NCT07272642 A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced… Imaging Not Yet Recruiting
Early Phase 1
NCT06824155 HEAT Trial (HER2 Antibody Therapy With Lutetium-177) HER2 Gene Mutation Recruiting
NCT06305962 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors PDL1 Gene Mutation Recruiting
Disease Areas
Get alerts when Radiopharm Theranostics, Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free